Utpal Koppikar

Utpal Koppikar

Director/Miembro de la Junta en C4 THERAPEUTICS, INC. .

Fortuna: - $ al 31/05/2026

55 años
Health Technology
Consumer Services
Technology Services

Perfil

Utpal Koppikar is currently an Independent Director at C4 Therapeutics, Inc. since 2022 and Chief Financial Officer at Verily Life Sciences LLC since 2023.
Former positions include Director at Flexion Therapeutics, Inc. in 2021, Vice President-Corporate & Operations Finance at Gilead Sciences, Inc. from 2017 to 2018, and Chief Financial Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2018 to 2023.
Education includes graduate studies at Stanford University, undergraduate studies at the University of Maryland, and an MBA from UCLA Anderson School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/06/2026 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Utpal Koppikar

EmpresasCargoInicio
C4 THERAPEUTICS, INC. Director/Miembro de la Junta 16/03/2022
Director Financiero/CFO 01/04/2023

Antiguos cargos conocidos de Utpal Koppikar.

EmpresasCargoFin
ATARA BIOTHERAPEUTICS, INC. Director Financiero/CFO 31/03/2023
FLEXION THERAPEUTICS, INC. Director/Miembro de la Junta 19/11/2021
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/06/2018
Ver el detalle de la experiencia de Utpal Koppikar.

Formación de Utpal Koppikar.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

35

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Technology Services

Health Technology